Sharp steps down as Ultragenyx CFO; plus Axsome, ElevateBio, FasterCures, Satsuma, WindMIL and more

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) said EVP and CFO Shalini Sharp will step down by Sept. 2 to focus on serving as an adviser and board member for various biotech companies. Sharp will remain with the rare diseases company to aid with the CFO transition for six

Read the full 462 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE